|
|
|
03 Jan 2008 |
Acambis reports positive data from trials of universal influenza A vaccine
|
|
03 Jan 2008 |
Avexa Initiates Phase III ATC Trial
|
|
03 Jan 2008 |
Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
|
|
31 Dec 2007 |
Ardea Biosciences' Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
|
|
24 Dec 2007 |
Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
|
|
21 Dec 2007 |
Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
|
|
21 Dec 2007 |
ISENTRESS(R) (raltegravir) from MSD, First Integrase Inhibitor, Approved by the European Union Commission
|
|
21 Dec 2007 |
Pfizer Receives Approvable Letter from FDA for Dalbavancin
|
|
21 Dec 2007 |
Medivir AB and Presidio Pharmaceuticals, Inc. Amend license agreement
|
|
21 Dec 2007 |
Aeras and Crucell Announce Start of a Tuberculosis Vaccine Clinical Trial in the United States. Aeras commits a further USD 5 million to the development of the tuberculosis vaccine
|
|
21 Dec 2007 |
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
|
|
20 Dec 2007 |
Successful Collaboration between US Army and Intercell Towards a Novel Vaccine Against JE
|
|
20 Dec 2007 |
Novavax Announces Favorable Interim Results From Human Clinical Trial
|
|
20 Dec 2007 |
Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis
|
|
19 Dec 2007 |
GlobeImmune Announces Initiation of Phase II Clinical Trial of GI-5005 in Patients with Chronic Hepatitis C
|
|
19 Dec 2007 |
GlaxoSmithKline and Santaris Pharma enter R&D alliance to discover, develop and comercialise RNA antagonists as novel antivirals
|
|
18 Dec 2007 |
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
|
|
17 Dec 2007 |
European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
|
|
16 Dec 2007 |
Inhibitex Reports Favorable Results from First Clinical Trial of FV-100
|
|
16 Dec 2007 |
Intercell receives Milestone Payment from Merck & Co. Inc.
|
|
13 Dec 2007 |
Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection
|
|
11 Dec 2007 |
ZymoGenetics Presents PEG-Interferon Lambda Phase 1a Data
|
|
11 Dec 2007 |
Chimerix Initiates a Multi-dose Clinical Trial of the Company’s Lead Compound, CMX001, for the Treatment for Smallpox Infection
|
|
06 Dec 2007 |
Intercell Submits Marketing Authorization Application (MAA) to EMEA for Licensure of Japanese Enceph
|
|
06 Dec 2007 |
AVANT Immunotherapeutics Achieves Immune Responses Against Cholera, Typhoid and Enterotoxigenic E. coli with a Single-Dose, Oral Combination Vaccine
|
|
06 Dec 2007 |
SIGA Completes 21 Day Multi-Dose Human Clinical Safety and Dose-Ranging Trial of Its Lead Smallpox Drug ST-246
|
|
06 Dec 2007 |
Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
|
|
05 Dec 2007 |
BioAlliance Pharma acquires the European commercialization rights to pafuramidine for the treatment of Pneumocystis carinii pneumonia
|
|
05 Dec 2007 |
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
|
|
04 Dec 2007 |
Myriad Genetics Submits IND on Vivecon
|
|
04 Dec 2007 |
SSI, Intercell and Aeras announce start of clinical trial for novel vaccine candidate against TB
|
|
30 Nov 2007 |
Avexa's ATC demonstrates activity against emerging
|
|
29 Nov 2007 |
Merck: Cyanokit Approved in the European Union
|
|
29 Nov 2007 |
Bavarian Nordic A/S reports positive data from first EUA enabling study with IMVAMUNE(R) smallpox vaccine
|
|
28 Nov 2007 |
Transport’s Phase 2 Data Show Single Treatment SoloVir(TM) ETS Significantly Stops Progression of Cold Sore Episode
|
|
28 Nov 2007 |
Manhattan Pharmaceuticals Announces Positive Clinical Results for Hedrin in Treatment of Head Lice
|
|
27 Nov 2007 |
NovaBay Announces Positive Phase I Study Results with Its Lead Aganocide Compound
|
|
27 Nov 2007 |
Barrier Therapeutics Announces Positive Results of Dose Escalation Clinical Safety Study With Pramiconazole
|
|
27 Nov 2007 |
Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine
|
|
26 Nov 2007 |
Maxygen Updates Status of MAXY-alpha Program
|
|
26 Nov 2007 |
Naryx Pharma Announces Completion of Enrollment of a Phase 2b Clinical Trial of Sybryx(TM) for Chronic Sinusitis
|
|
23 Nov 2007 |
New data published in The Lancet show GSK's rotavirus vaccine Rotarix(R) offers sustained and broad protection against all common circulating rotavirus types
|
|
21 Nov 2007 |
Initiation of a Phase IIA Clinical Trial with Investigational Hepatitis C Protease Inhibitor TMC435350
|
|
20 Nov 2007 |
Positive outcome of drug-drug interaction trial with intravenous iclaprim
|
|
20 Nov 2007 |
Avexa gets green light for ATC Phase III program
|
|
19 Nov 2007 |
Pacgen Initiates a Phase IIb Clinical Trial For PAC-113
|
|
19 Nov 2007 |
Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
|
|
19 Nov 2007 |
Inhibitex Obtains License To HCV Polymerase Inhibitors
|
|
16 Nov 2007 |
BioAlliance Pharma completes patient enrolment ahead of schedule for its pivotal phase III clinical trial of Loramyc(R) in the USA for the treatment of oropharyngeal candidiasis
|
|
15 Nov 2007 |
Sanofi Pasteur and Acambis join forces to bring West Nile vaccine to market
|
| |
|
Results 351 - 400 of 1267 |
